Acurx Pharma Prices $7.1 Mln Offering Of Shares And Short-Term Warrants; Stock Down

Acurx Pharmaceuticals announced a registered direct offering for 825,000 shares at $3.03 per share. The capital raise is a routine financing event but may modestly pressure the stock due to dilution concerns. No operational update or clinical catalyst was included in the article.

Analysis

Acurx Pharmaceuticals announced a registered direct offering for 825,000 shares at $3.03 per share. The capital raise is a routine financing event but may modestly pressure the stock due to dilution concerns. No operational update or clinical catalyst was included in the article.